Senior Scientist, Medicinal Chemistry at Hexagon Bio

Menlo Park, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Scientist I: Ph.D. in organic or medicinal chemistry, and 0+ years postdoctoral and/or industry experience
Scientist II: Ph.D. in organic or medicinal chemistry, and 2+ years postdoctoral and/or industry experience
Senior Scientist: Ph.D. in organic or medicinal chemistry, and 4+ years postdoctoral and/or industry experience
Ability to perform complex multistep synthesis quickly, efficiently, and safely
Ability to effectively summarize and communicate research findings
Ability to work full-time onsite at Menlo Park, CA laboratories

Responsibilities

Structure-based and hypothesis-driven design of new ADC payload and linker-payload drug compounds
Multistep synthesis, purification, and characterization of new ADC payload and linker-payload drug compounds
May manage aspects of a drug discovery program
May manage chemistry at a contract research organization

Skills

Medicinal Chemistry

Organic Chemistry

Multistep Synthesis

Structure-Based Design

Purification

Characterization

Drug Discovery

ADC Payloads

Linker-Payload Compounds

Hexagon Bio

Biotechnology firm developing medicines using genomics

About Hexagon Bio

Hexagon Bio specializes in discovering and developing new medicines using synthetic biology and data science. They analyze genomic data from various species to identify small molecule inhibitors that target proteins involved in diseases like cancer. Their unique platform allows for rapid production of lead compounds, enabling faster clinical development compared to traditional methods. The company's goal is to create effective treatments for complex diseases and license their drug candidates to larger pharmaceutical companies.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$178.6MTotal Funding

LATE_VCCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Flexible Work Hours

Gym Membership

Risks

Faces competition from biotech companies like Insitro and Recursion Pharmaceuticals.

Requires continuous updates to their platform due to rapid technological advancements.

Relies on external funding, posing financial risks if future funding is scarce.

Differentiation

Hexagon Bio uses synthetic biology to discover drugs from fungal genomes.

Their proprietary platform combines data science and synthetic biology for drug discovery.

Hexagon Bio's team includes experts in computational biology, biochemistry, and software engineering.

Upsides

Raised $77.3 million in Series B financing to expand their discovery platform.

Leverages reduced DNA sequencing costs to access vast genomic data.

Partnerships in AI and machine learning enhance drug discovery efficiency.

Land your dream remote job 3x faster with AI

Try Jobo Free